Ramiro Martin Cabral - 01 Mar 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President - Elanco International
Signature
/s/ Collin G. Smyser, Attorney-in-Fact for Ramiro M. Cabral
Issuer symbol
ELAN
Transactions as of
01 Mar 2022
Net transactions value
-$91,033
Form type
4
Filing time
03 Mar 2022, 20:04:07 UTC
Previous filing
24 Feb 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +12,699 +17% $0.000000 86,084 01 Mar 2022 Direct F1
transaction ELAN Common Stock Tax liability $54,754 -1,892 -2.2% $28.94 84,192 01 Mar 2022 Direct F2
transaction ELAN Common Stock Tax liability $36,279 -1,251 -1.5% $29.00 82,941 02 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +33,747 $0.000000 33,747 01 Mar 2022 Common Stock 33,747 $28.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F3 Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.

Remarks:

Executive Vice President - Elanco International